Martin Wabitsch
Expertise in
24
conditions

Martin Wabitsch

Albert Einstein Allee 11, 
Ulm, BW, DE 
Expertise in
24
conditions
Albert Einstein Allee 11, 
Ulm, BW, DE 

Overview

Martin Wabitsch practices practicing medicine in Ulm, Germany.

Mr. Wabitsch is highly rated in 24 conditions, according to our data. His clinical expertise encompasses Obesity, Obesity in Children, Simpson-Golabi-Behmel Syndrome, Hormone Replacement Therapy (HRT), and Gastric Bypass.

He is actively involved in clinical research, co-authoring 375 peer reviewed articles and participating in 4 clinical trials.

Gender

Male

Locations

Albert Einstein Allee 11, Ulm, BW 89081, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Long Term Extension Trial of Setmelanotide (RM-493) for Patients Who Have Completed a Trial of Setmelanotide for the Treatment of Obesity Associated With Genetic Defects Upstream of the MC4 Receptor in the Leptin-melanocortin Pathway
Long Term Extension Trial of Setmelanotide (RM-493) for Patients Who Have Completed a Trial of Setmelanotide for the Treatment of Obesity Associated With Genetic Defects Upstream of the MC4 Receptor in the Leptin-melanocortin Pathway
Enrollment Status: Completed
Publish Date: May 31, 2025
Intervention Type: Drug
Study Drug: Setmelanotide
Study Phase: Phase 2/Phase 3
Effectiveness and Safety of Weight Loss Surgery in Adolescents With Extreme Obesity Within a Structured Pre- and Post-surgery Treatment Program, Subproject 3
Effectiveness and Safety of Weight Loss Surgery in Adolescents With Extreme Obesity Within a Structured Pre- and Post-surgery Treatment Program, Subproject 3
Enrollment Status: Active_not_recruiting
Publish Date: May 08, 2024
Intervention Type: Procedure, Other
Setmelanotide (RM-493) Phase 2 Treatment Trial in Patients With Rare Genetic Disorders of Obesity
Setmelanotide (RM-493) Phase 2 Treatment Trial in Patients With Rare Genetic Disorders of Obesity
Enrollment Status: Completed
Publish Date: August 18, 2023
Intervention Type: Drug
Study Drug: Setmelanotide
Study Phase: Phase 2
An Open Label, 1-Year Trial, Including a Double-Blind Placebo-Controlled Withdrawal Period, of Setmelanotide (RM-493), a Melanocortin 4 Receptor (MC4R) Agonist, in Leptin Receptor (LEPR) Deficiency Obesity Due to Bi-Allelic Loss-of-Function LEPR Genetic Mutation
An Open Label, 1-Year Trial, Including a Double-Blind Placebo-Controlled Withdrawal Period, of Setmelanotide (RM-493), a Melanocortin 4 Receptor (MC4R) Agonist, in Leptin Receptor (LEPR) Deficiency Obesity Due to Bi-Allelic Loss-of-Function LEPR Genetic Mutation
Enrollment Status: Completed
Publish Date: May 23, 2023
Intervention Type: Drug
Study Phase: Phase 3
View 3 Less Clinical Trials

375 Total Publications

European Consortium for Lipodystrophies consensus definition and classification framework for monogenic lipodystrophy.
European Consortium for Lipodystrophies consensus definition and classification framework for monogenic lipodystrophy.
Journal: Journal of internal medicine
Published: September 02, 2026

Frequently Asked Questions about Martin Wabitsch

Is Martin Wabitsch a top-rated expert for Obesity?

MediFind is an objective health platform that identifies experts based on real-world data. Martin Wabitsch is classified as an Elite expert for Obesity, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Martin Wabitsch participate in research or clinical trials?

Yes. Martin Wabitsch has published 375 articles and abstracts on conditions like Obesity. You can view a list of Martin Wabitsch's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Wabitsch's expertise for a condition
ConditionClose
View All 16 Advanced Conditions
View All 46 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile